相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients
Patrick Roth et al.
EUROPEAN JOURNAL OF CANCER (2015)
CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma
Aurelien Viaccoz et al.
NEURO-ONCOLOGY (2015)
CD44v10, osteopontin and lymphoma growth retardation by a CD44v10-specific antibody
Amelie Pajip Megaptche et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors
Yi-Peng Han et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Role of osteopontin in the pathophysiology of cancer
Lalita A. Shevde et al.
MATRIX BIOLOGY (2014)
Postoperative Serum Osteopontin Level is a Novel Monitor for Treatment Response and Tumor Recurrence after Resection of Hepatitis B-related Hepatocellular Carcinoma
Chuang Zhou et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
James L. Rubenstein et al.
BLOOD (2013)
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Ane Kongsgaard Rud et al.
BMC CANCER (2013)
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project
Jacoline E. Bromberg et al.
HAEMATOLOGICA (2013)
Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression
Ji Yuan et al.
HUMAN PATHOLOGY (2013)
Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage
Yasuto Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity
Levente Szalardy et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Diagnosis and treatment of primary CNS lymphoma
Agnieszka Korfel et al.
NATURE REVIEWS NEUROLOGY (2013)
Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
PANCREAS (2013)
Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer
Seon-Sook Han et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2013)
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
A. Korfel et al.
ANNALS OF ONCOLOGY (2012)
Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Alexander Baraniskin et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients
Shi-Rong Wen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)
Takashi Sasayama et al.
NEURO-ONCOLOGY (2012)
Surgery for primary CNS lymphoma? Challenging a paradigm
Michael Weller et al.
NEURO-ONCOLOGY (2012)
Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis
Yong Li et al.
MEDICAL ONCOLOGY (2012)
Osteopontin: A key link between immunity, inflammation and the central nervous system
Amanda Brown
TRANSLATIONAL NEUROSCIENCE (2012)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma
M. Deckert et al.
LEUKEMIA (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
Jianxin Dai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology
Roland Schroers et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Differential gene expression in central nervous system lymphoma
James L. Rubenstein et al.
BLOOD (2009)
CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
Lars Fischer et al.
CLINICAL CANCER RESEARCH (2009)
Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis
Manjit Braitch et al.
ARCHIVES OF NEUROLOGY (2008)
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis
Soheli A. Chowdhury et al.
ARCHIVES OF NEUROLOGY (2008)
Pathway analysis of primary central nervous system lymphoma
Han W. Tun et al.
BLOOD (2008)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model
A Hollender et al.
ANNALS OF ONCOLOGY (2002)
CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes
B Gleissner et al.
NEUROLOGY (2002)
分享论文
